Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

Go back to Beam Therapeutics Announces Pipeline and Business Highlights and Reports Second Quarter 2022 Financial Results

Beam, Inc. (BEAM) Tops Q2 EPS by 10c

August 9, 2022 6:31 AM EDT

Beam, Inc. (NASDAQ: BEAM) reported Q2 EPS of ($1.02), $0.10 better than the analyst estimate of ($1.12). Revenue for the quarter came in at $16.65 million versus the consensus estimate of $8.39 million.

For earnings history and earnings-related data on Beam, Inc. (BEAM) click here.

... More